The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study

BACKGROUND: Studies suggest that patients with metastases limited in number and destination organ benefit from metastasis-directed therapy. Stereotactic body radiotherapy (SBRT) is commonly used for metastasis directed therapy in this group. However, the characterization of PET response following SB...

Descripción completa

Detalles Bibliográficos
Autores principales: Solanki, Abhishek A, Weichselbaum, Ralph R, Appelbaum, Daniel, Farrey, Karl, Yenice, Kamil M, Chmura, Steven J, Salama, Joseph K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551831/
https://www.ncbi.nlm.nih.gov/pubmed/23244066
http://dx.doi.org/10.1186/1748-717X-7-216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551831/
https://www.ncbi.nlm.nih.gov/pubmed/23244066
http://dx.doi.org/10.1186/1748-717X-7-216

Ejemplares similares